US$ 25.61
what is the mechanism of action of glp 1 agonists Mechanisms GLP-1RA Glucagon-like peptide-1 receptor: mechanisms and
Description
Bariatric Fusion GLP-ONE + Receptor Activator features two clinically validated botanical ingredients: hops extract (20% xanthohumulone) and copaiba extract (10% beta-caryophyllene)

Obesity is a growing epidemic that affects millions of people worldwide, leading to serious health complications such as heart disease, diabetes, and certain cancers

Ozempic is the hottest drug on the market for weight loss

Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.

This has increased interest in pharmacological treatment options
